Bartsch, R
Abstract Background Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are widely used for the management of type 2 diabetes and obesity, yet their long-term cardiovascular effects in high-risk populations continue to be actively evaluated
During this session, we will perform a physical examination, record your current weight, and review your complete medical history, including any medications, allergies, past treatments, and pre-existing conditions
No published randomized, controlled clinical trial has evaluated BPC-157 including ProHealth's specific formulation for any human health indication
Although not available for purchase yet, Retatrutide for obesity and weight loss might be the most effective medication of all available when it is launched
Patients taking Tradjenta 5mg will typically be able to lower their A1C scores although it can take several weeks on the medication to start seeing these results